The past five years have witnessed tremendous growth in the field of g
ene therapy, with pre-clinical and clinical gene therapy trials for di
seases as diverse as cancer, AIDS and atherosclerosis, These studies h
ave utilized many different vectors and target organs in order to achi
eve therapeutic effects, In this review, we examine the rationale for
using skeletal muscle as a target tissue for gene therapy, discuss the
wide array of vectors that have been used for muscle-based gene thera
py, summarize the disease-targets that have been approached using thes
e techniques, and discuss some of the obstacles that remain to be over
come en route to successful muscle-based human gene therapy.